Preferred Label : magnesium carbonate;

MeSH note : RN given refers to parent cpd (1:1);

CISMeF synonym : nesquehonite; magnesite;

MeSH synonym : carbonic acid, magnesium salt (1:1), hydrate; magnesium carbonate (1:1) hydrate;

MeSH hyponym : MgCO3.3H2O; CI 77713;

Related MeSH term : anhydrous magnesium carbonate; magnesium carbonate anhydrous; magnesite (Mg(CO3));

MeSH Related Number : 13717-00-5 (magnesite); 7757-69-9 (unspecified mg salt); 546-93-0; 0IHC698356; 546-93-0 (magnesite);

Libelles Related CAS CISMeF : acide carbonique, sel de magnésium;

Registry Number MeSH : 546-93-0;

related registry number list (CISMeF) : 13717-00-5 (magnesite); 7757-69-9 (unspecified Mg salt);

Codes EINECS : 208-915-9;

Is substance : O;

medicament (CISMeF) : O;

UNII : 0E53J927NA;

InChIKey : OUHCLAKJJGMPSW-UHFFFAOYSA-L;

Details


Main resources

You can consult :


https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=9282&nom=Carbonate+de+magnésium
Canada
toxicological data sheet
magnesium
carbonates
magnesium carbonate

---
http://www.has-sante.fr/portail/jcms/c_1278289/osvaren-acetate-de-calcium-carbonate-de-magnesium-hypophosphoremiant
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
magnesium
acetates
calcium compounds
drug combinations
administration, oral
calcium acetate
magnesium carbonate
chelating agents
hyperphosphatemia
renal insufficiency, chronic
calcium acetate and magnesium carbonate
insurance, health, reimbursement
renal dialysis
adult
treatment outcome
clinical trials, phase iii as topic
comparative study

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/osvaren_28032012_avis_ct11951.pdf
http://www.has-sante.fr/portail/jcms/c_1242858/osvaren
2012
false
France
French
evaluation of the transparency committee
chelating agents
chelating agents
drug combinations
administration, oral
insurance, health, reimbursement
magnesium carbonate
magnesium carbonate
calcium acetate
calcium acetate
calcium acetate and magnesium carbonate
renal insufficiency, chronic
renal dialysis
adult
treatment outcome
clinical trials as topic
magnesium
magnesium
acetates
acetates
calcium compounds
calcium compounds
hyperphosphatemia
comparative study

---
http://www.has-sante.fr/portail/jcms/c_1225078/topaal
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/topaal_15022012_avis_ct11313_ct9035.pdf
http://www.has-sante.fr/portail/jcms/c_632374/topaal
2012
France
French
drug combinations
administration, oral
magnesium carbonate
algeldrate
aluminum hydroxide
silicon dioxide
gastroesophageal reflux
esophagitis
antacids, other combinations
treatment outcome
adult
pregnancy
insurance, health, reimbursement
magnesium
alginates
hexuronic acids
glucuronic acid
antacids
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_632366
http://www.has-sante.fr/portail/jcms/c_1323137/gastropulgite
http://www.has-sante.fr/portail/jcms/c_1221607/gastropulgite
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/gastropulgite_15022012_avis_ct11172.pdf
2012
France
French
treatment outcome
drug combinations
silicon compounds
aluminum hydroxide
gastroesophageal reflux
attapulgite, combinations
administration, oral
attapulgite
magnesium compounds
magnesium carbonate
magnesium
insurance, health, reimbursement
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1339915/topaal
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12395_TOPAAL_21112012_AVIS_CT12395.pdf
2012
France
French
administration, oral
insurance, health, reimbursement
drug combinations
gastroesophageal reflux
adult
esophagitis
drug therapy, combination
evaluation of the transparency committee
magnesium carbonate
aluminum hydroxide
silicon dioxide
antacids, other combinations
magnesium
alginates
hexuronic acids
glucuronic acid

---
http://www.has-sante.fr/portail/display.jsp?id=c_400532
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032109.pdf
2005
France
French
administration, oral
drug combinations
betaine
drugs for bile therapy and lipotropics in combination
magnesium carbonate
magnesium
ornithine
citric acid
sorbitol
treatment outcome
dyspepsia
magnesium
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032169.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400592
2005
France
French
drug combinations
administration, oral
magnesium carbonate
magnesium
flavonoids
ascorbic acid
venous insufficiency
treatment outcome
magnesium
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032086.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400509
2005
France
French
treatment outcome
magnesium pidolate
dietary supplements
magnesium deficiency
magnesium
administration, oral
pyrrolidonecarboxylic acid
magnesium carbonate
magnesium
magnesium
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031999.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400422
2005
France
French
evaluation of the transparency committee
administration, oral
drug combinations
citric acid
citrates
choline
magnesium carbonate
magnesium
treatment outcome
dyspepsia
drugs for bile therapy and lipotropics in combination
magnesium
citrates
Sodium Citrate

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.